Le Lézard
Classified in: Health
Subjects: RCL, PSF, CFG

Updated Food Recall Warning - Consumption of certain apricot kernel products may cause cyanide poisoning


Product photos are available at: https://bit.ly/3rLr2fr 

OTTAWA, April 1, 2021 /CNW/ - The food recall warning issued on March 12, 2021 has been updated to include additional product information. This additional information was identified during the Canadian Food Inspection Agency's (CFIA) food safety investigation.

Industry is recalling certain apricot kernels products from the marketplace due to natural toxin amygdalin. Consumers should not consume the recalled products described below as they contain excessive amygdalin which may cause acute cyanide poisoning.

The following products have been sold as indicated in the table below.

Recalled products

Brand

Product

Size

UPC

Codes

Additional Information

None

"Armeniacal",

product code

590080

Variable

None

None

Sold from January 21, 2020 to April 30, 2020

inclusively at:

Nutri Herbs: Unit 1065- 1163 Pinetree Way,

Coquitlam, British Columbia and

Nice Herbs: Unit 101M -15277 100 Ave.,

Surrey, British Columbia.

None

"Armeniacal",

product code

590090

Variable

None

None

Sold from January 21, 2020 to April 30, 2020

inclusively at:

Nutri Herbs: Unit 1065- 1163 Pinetree Way,

Coquitlam, British Columbia and

Nice Herbs: Unit 101M -15277 100 Ave.,

Surrey, British Columbia.

What you should do

If you think you became sick from consuming a recalled product, call your doctor.

Check to see if you have the recalled products in your home. Recalled products should be thrown out or returned to the store where they were purchased.

Apricot kernels naturally contain amygdalin, which can release cyanide after being eaten. The human body can eliminate small amounts of cyanide, but larger amounts can result in cyanide poisoning, which could lead to death.

Symptoms of cyanide poisoning include weakness and confusion, anxiety, restlessness, headache, nausea, difficulty breathing and shortness of breath, loss of consciousness, seizures and cardiac arrest.

Background

This recall was triggered by CFIA test results. The CFIA is conducting a food safety investigation, which may lead to the recall of other products. If other high-risk products are recalled, the CFIA will notify the public through updated Food Recall Warnings.

The CFIA is verifying that industry is removing the recalled products from the marketplace.

Illnesses

There have been no reported illnesses associated with the consumption of these products.

SOURCE Canadian Food Inspection Agency (CFIA)


These press releases may also interest you

at 00:39
World Malaria Day is marked each year on April 25. World Health Organization (WHO) gave as the theme for World Malaria Day 2024 Accelerating the fight against malaria for a more equitable world. WHO stated that malaria not only continues to directly...

25 avr 2024
The report titled "Anti-Adhesion Products Market by Product Type (Natural Adhesion Barriers, Synthetic Adhesion Barriers), Product Form (Film Formulation, Gel Formulation, Liquid Formulation), Application, End-User - Global Forecast 2024-2030" is now...

25 avr 2024
Product: Meat and vegetable products Issue: Food - Microbial Contamination - Listeria Distribution:British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

25 avr 2024
The report titled "Contract Research Organization Services Market by Type (Clinical Research Services, Consulting Services, Data Management Services), Trial Phase (Phase I, Phase II, Phase III), Therapeutic Area, Molecule Type, End-User - Global...

25 avr 2024
Greenbrook TMS Inc. ("Greenbrook" or the "Company") today announced its fiscal year ended December 31, 2023 ("Fiscal 2023") operational and financial results. All values in this news release are in United States dollars, unless otherwise stated....

25 avr 2024
AIDS Healthcare Foundation applauds the government of Colombia for issuing a compulsory license on HIV drug dolutegravir, which will allow the country to access affordable generic versions of the treatment as an alternative to the costly branded...



News published on and distributed by: